Plus Therapeutics, Inc.
Austin, TX Doing business as Cytori
- UEI
- NUN2VLR3MZD6
- CAGE
- 4AW88
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4200 Marathon Blvd #200, Austin, TX 78756, USA
- Website
- plustherapeutics.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| (no IDC) development of a novel targeted radiotherapeutic for the treatment of pediatric high-grade glioma (HGG) and… | Defense Health Agency | $2,985,093 | |
| Change of name from cytori therapeutics, INC. To plus therapeutics, INC. | Office of the Assistant Secretary for Preparedness and Response | $33,803,118 | |
| Adipose tissue-derived cells for vascular cell therapy | National Institutes of Health | $249,877 | |
| Wrap-surgi-130MMX200MMX0.5MM | Veterans Integrated Service Network 5 | $2,250 | |
| Wrap-surgi-100MMX130MMX0.5MM | Veterans Integrated Service Network 5 | $2,225 |
Quick answers
What is Plus Therapeutics, Inc.'s UEI?
Plus Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is NUN2VLR3MZD6.
What is Plus Therapeutics, Inc.'s CAGE code?
Plus Therapeutics, Inc.'s CAGE code is 4AW88.
What is Plus Therapeutics, Inc.'s primary NAICS code?
Plus Therapeutics, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Plus Therapeutics, Inc. located?
Plus Therapeutics, Inc.'s physical address in SAM.gov is 4200 Marathon Blvd #200, Austin, TX 78756, USA.
Is Plus Therapeutics, Inc. registered in SAM.gov?
Yes. Plus Therapeutics, Inc.'s SAM.gov registration is active through January 29, 2027.
What is Plus Therapeutics, Inc.'s most recent federal award?
Plus Therapeutics, Inc.'s most recent federal grant award is (no IDC) development of a novel targeted radiotherapeutic for the treatment of pediatric high-grade glioma (HGG) and… (HT94252411035), from Defense Health Agency, on September 1, 2024.
On GovTribe
See Plus Therapeutics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors